Abstract
Objective
To investigate the effect of a specific inhibitor PD098059 of the extracellular-signal regulated protein kinase (ERK) pathway on the P -glycoprotein (P-gp)-mediated resistance of colon cancer cell lines SW480/ VCR and CoLo205A/CR.
Methods
SW480/VCR and CoLo205/VCR cells were generated by exposuring SW480 and CoLo205 cells to vincristine (VCR) (30 ng/ml) for 72 h, which resulted in a comparatively higher level of P -gp expression. Western blotting was used to analyze P-gp, MRP, LRP, GST-π and TOPOII expression after exposuring the SW480 and CoLo205 cells to VCR (30 ng/ml) for 72 hrs. P-gp and pERK1/2 expressions was analyzed in SW480/VCR and CoLo205/VCR cells treated with or without the specific inhibitor of MEK, PD098059. The MTT assay was used to determine the susceptibility of SW480/VCR and CoLo205/VCR cells to VCR, treated with or without PD098059.
Results
The results showed that VCR induced a comparatively higher level of P-gp expression in the cell lines, but not that of MRP, LRP, GST-π or TOPOII. P-gp expression levels were depressed significantly in SW480/ VCR and COLO205/VCR cells by the specific inhibitor of MEK, PD098059. The IC50 (248 ±19.6 and 215 ±10.7 ng/ml) to VCR of SW480/VCR and CoLo205/VCR cells exhibited a 2.16 and 2.03 -fold higher resistance compared to the negative control group (SW480 and CoLo205 cells)(115± 15.6 and 106 ±11.9 ng/ml), but a 1.35 and 1.21-fold higher resistance than the group treated with VCR (30 ng/ml) + PD098059 (184 ± 21.8 and 177± 19.4 ng/ml).
Conclusion
This study shows that the expression of P -gp can be induced by exposuring cells to VCR, and that this induction can be reversed by inhibiting the ERK signaling pathway at the point of MEK by its specific inhibitor, PD098059. The ERK signal-transduction pathway may play a role in modulating mdr1 expression in colon cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Stavrovskaya AA. Cellular mechanisms of multidrug resistance of tumor cells. Biochemistry (Mosc). 2000; 1:95–106.
Goldstein LJ, Galski H, Fojo A, et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst. 1989; 2:116–124.
Holzmayer TA, Hilsenbeck S, Von Hoff DD, et al. Clinical correlates of MDR1 (P -glycoprotein) gene expression in ovarian and small-cell lung carcinomas. J Natl Cancer Inst. 1992; 19:1486–1491.
Fojo T, Bates S. Strategies for reversing drug resistance. Oncogene. 2003; 47:7512–7523.
Chan HS, Haddad G, Thorner PS, et al. P -glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med. 1991; 23:1608–1641.
Chaudhary PM, Roninson IB. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst. 1993; 8:632–639.
Takara K, Tsujimoto M, Kokufu M, et al. Up-regulation of MDR1 function and expression by cisplatin in LLC-PK1 cells. Biol Pharm Bull. 2003; 2:205–209.
Seger R, Krebs EG. The MAPK signaling cascade. FASEB J. 1995; 9:726–735.
Persons DL, Yazlovitskaya EM, Cui W, et al. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin Cancer Res. 1999; 5:1007–1014.
Kisucka J, Barancik M, Bohacova V, et al. Reversal effect of specific inhibitors of extracellular-signal regulated protein kinase pathway on P -glycoprotein mediated vincristine resistance of L1210 cells. Gen Physiol Biophys. 2001; 4: 439–444.
Mandic A, Viktorsson K, Heiden T. The MEK1 inhibitor PD98059 sensitizes C8161 melanoma cells to cisplatin-induced apoptosis. Melanoma Res. 2001 ; 1:11–19.
Sebolt-Leopold JS. Development of anticancer drugs targeting the MAP kinase pathway. Oncogene. 2000; 56: 6594–6599.
Tomida A, Naito M, Tsuruo T. Acute induction of adriamycin-resistance in human colon carcinoma HT -29 cells exposed to a sublethal dose of adriamycin. Jpn J Cancer Res. 1995; 2:224–232.
Chen B, Yang J, Jin F, et al. The effect of PD098059 on apoptosis of human gastric cancer cells MGC803 induced by VCR. J Chin Med Univ. 2003; 2:140–142.
Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res. 1998; 1:149–159.
Jin F, Fan H, Ren S, et al. Upregulation of non-mutated liras and its upstream and downstream signaling proteins in colorectal cancer. Oncol Rep. 2001; 6:1409–1413.
Dent P, Jarvis WD, Birrer MJ, et al. The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway; a potential route to radio- and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity. Leukemia. 1998; 12:1843–1850.
Ding S, Chamberlain M, McLaren A, et al. Cross-talk between signalling pathways and the multidrug resistant protein MDR-1. Br J Cancer. 2001; 8:1175–1184.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Jin, F., Fan, H., Chen, B. et al. Ability of a specific ERK signal-pathway inhibitor to reverse P-glycoprotein-mediated vincristine resistance in colon cancer cell lines. Chin. J. Clin. Oncol. 1, 295–300 (2004). https://doi.org/10.1007/BF02739816
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02739816